Association of 18bp insertion/deletion polymorphism, at -2549 position of VEGF gene, with diabetic nephropathy in type 2 diabetes mellitus patients of North Indian population.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 4407794)

Published in J Diabetes Metab Disord on March 27, 2015

Authors

Dnyanesh Amle1, Rashid Mir2, Alka Khaneja1, Sarita Agarwal1, Ravinder Ahlawat3, Prakash C Ray1, Alpana Saxena1

Author Affiliations

1: Department of Biochemistry, Cancer Genetics Laboratory, Maulana Azad Medical College and associated hospitals, New Delhi, 110002 India.
2: PRINCE FAHD BIN SULTAN RESEARCH CHAIR, Division of Molecular Genetics, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, 71491 Saudi Arabia.
3: Department of Medicine, Maulana Azad Medical College and associated Hospitals, New Delhi, 110002 India.

Articles cited by this

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (1983) 15.43

The biology of vascular endothelial growth factor. Endocr Rev (1997) 13.70

Pathophysiological consequences of VEGF-induced vascular permeability. Nature (2005) 4.08

Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine (2000) 3.22

VEGF-A splicing: the key to anti-angiogenic therapeutics? Nat Rev Cancer (2008) 3.02

A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res (2001) 2.70

A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes (2002) 2.46

Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol (2004) 2.44

The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab (2008) 2.34

Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes (1999) 2.16

Trends in prevalence of diabetes in Asian countries. World J Diabetes (2012) 1.96

The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med (2000) 1.86

Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol (2002) 1.84

Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int (2006) 1.59

Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene. Hum Immunol (1999) 1.45

Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy. Kidney Int (2005) 1.41

Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes (2004) 1.36

Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes (1997) 1.22

Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: localization and [125I]VEGF binding sites. J Am Soc Nephrol (1998) 1.22

Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes. Biochem Biophys Res Commun (2005) 1.19

Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? 1962. Bull World Health Organ (1999) 1.19

Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients. Nephrol Dial Transplant (2006) 1.15

Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. J Diabetes Complications (2002) 1.14

Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy. Am J Kidney Dis (2005) 1.11

Genetics of diabetic nephropathy. Ther Adv Cardiovasc Dis (2008) 1.05

Nutrient-mediated teratogenesis and fuel-mediated teratogenesis: two pathways of intrauterine programming of diabetes. Int J Gynaecol Obstet (2009) 1.05

Phenotypic modulation of the mesangium reflected by contractile proteins in diabetes. Diabetes (1996) 0.92

What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications? PLoS One (2013) 0.90

Improved prognosis of diabetic nephropathy in type 1 diabetes. Kidney Int (2014) 0.88

New vessel formation in the renal corpuscles in advanced diabetic glomerulopathy. J Diabet Complications (1988) 0.88

Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patients. Ann Rheum Dis (2006) 0.83

Angiogenesis and vascular endothelial growth factor (VEGF): is it relevant in renal patients? Nephrol Dial Transplant (1995) 0.83

Vascular endothelial growth factor gene polymorphisms in North Indian patients with recurrent miscarriages. Reprod Biomed Online (2010) 0.81